美股A股
StockGist

The Cooper Companies, Inc.

COONASDAQ · Healthcare · Medical - Instruments & Supplies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
$62.65+0.74%
报价 2026-11-13
市值
$11.91B
EV
$13.32B
PE (TTM)
19.1x
预期 PE (FY2027)
13.4x
52 周区间距高点 -25.7%
$53.27$84.32

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22028-101.1x4.61 → 5.08(1.1x)12.3
FY+32029-101.2x4.61 → 5.53(1.2x)11.3

毛利率 64% · TTM 收入 $4237M · 基数 EPS 4.61(调整后)

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
COOThe Cooper Companies, Inc.$11.91B+0.7%+4.0%62.4%19.1x14.6x16.1x
NBIXNeurocrine Biosciences, Inc.$16.94B-1.2%+40.2%97.6%25.0x18.4x17.0x高增长
SOLVSolventum Corporation$15.14B+0.3%-0.0%53.5%7.3x5.5x–
ICLRICON Public Limited Company$14.58B-2.9%+1.6%19.6%34.7x13.4x12.2x
SNNSmith & Nephew plc$13.09B+0.9%–68%22.0x10.3x–
TEMTempus AI, Inc.$12.7B-5.7%+26.4%64.8%–––
FMSFresenius Medical Care AG & Co. KGaA$11.78B+2.0%–25.6%11.0x6.1x–Cheap
SMMTSummit Therapeutics Inc.$11.29B-6.1%-94.2%0%–––
UHSUniversal Health Services, Inc.$9.78B+0.1%+7.1%9.6%8.2x5.8x9.1xCheap
同行中位数––+4.4%39.5%16.5x8.2x12.2x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-07-31
Q3 2026
2026-04-30
Q2 2026
2026-01-31
Q1 2026
2025-10-31
Q4 2025
2025-07-31
Q3 2025
2025-04-30
Q2 2025
2025-01-31
Q1 2025
2024-10-31
Q4 2024
Revenue$1.07B$1.08B$1.02B$1.07B$1.06B$1B$964.7M$1.02B
Gross Margin62.4%68%67.9%56.4%65.3%67.8%68.4%66.5%
Operating Margin20.9%-2.9%20.8%13.2%16.6%18.4%18.9%19.5%
Net Income$432.8M$-77.9M$130.8M$84.6M$98.3M$87.7M$104.3M$117.5M
Diluted EPS2.24-0.40.660.430.490.440.520.58
Operating Cash Flow$341.7M$182.8M$260.9M$247.9M$261.4M$96.2M$190.6M$268.1M

研究材料